Articles about Corbevax

DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years

26 Apr 2022

India
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years

In a significant move, the Drugs Controller General of India (DCGI) on Tuesday cleared two COVID-19 vaccines for use in children aged between five and 12 years.

COVID-19 vaccination for 12-14 years begins; here's how to register

16 Mar 2022

India
COVID-19 vaccination for 12-14 years begins; here's how to register

India on Wednesday started vaccination of children aged 12 to 14 years as it expands its COVID-19 vaccination coverage.

Biological E's Corbevax vaccine approved for children aged 12-18 years

21 Feb 2022

India
Biological E's Corbevax vaccine approved for children aged 12-18 years

The Drugs Controller General of India (DCGI) has granted an emergency use authorization (EUA) to Corbevax—a COVID-19 vaccine developed by Hyderabad-based Biological E—for use in children aged between 12 and 18 years.

COVID-19 vaccine Corbevax's samples cleared by India's apex testing laboratory

06 Nov 2021

India
COVID-19 vaccine Corbevax's samples cleared by India's apex testing laboratory

Hyderabad-based pharmaceutical company Biological E's COVID-19 vaccine Corbevex's samples were cleared by the Central Drugs Laboratory in Kasauli on Tuesday.

Phase 2/3 trials of Corbevax on 5-18 age group permitted

02 Sep 2021

India
Phase 2/3 trials of Corbevax on 5-18 age group permitted

The Drugs Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct phase 2/3 clinical trials of its "Made in India" COVID-19 vaccine, Corbevax, on children aged between 5 and 18 years with certain conditions, sources said.